Royal Numico N.V. intends to appoint Mr. Rudy Mareel as a new member to the Executive Board. He will be responsible for the newly formed Clinical Nutrition Division. Rudy Mareel expects to join Numico in the course of the second quarter of 2003. During the presentation of the full year results 2002, the reflection of the core business at the highest organisational level was highlighted as one of the short-term goals in building a transparent and goal oriented organisation.
Jan Bennink, CEO of Numico: “This appointment underlines our determination to quickly implement our strategy to become a high-growth/high-margin specialised nutrition player. We are very pleased that Rudy Mareel has decided to join our organisation. The appointment of Rudy Mareel is the next step in implementing the renewed strategic focus on Clinical Nutrition, alongside Baby Food and GNC, which is a prerequisite to achieve our business goals.”
The appointment of Rudy Mareel as a member to the Executive Board will be proposed to the General Meeting of Shareholders to be held on 9 May 2003.
Rudy Mareel, 39 years old, with Belgium nationality, obtained an MSc in Clinical Chemistry at the University of Ghent (Belgium). He started his career in 1987 at the Diagnostic Division of Abbott before joining Becton Dickinson (BD), a medical technology company, in 1991 as Sales Manager Benelux Immunocytometry Systems. He also worked as Managing Director BD Germany, Switzerland and Austria before moving into the position of VP and General Manager Europe BD Biosciences based in Germany. His most recent position was Worldwide Vice President/General Manager BD Biosciences, Immunocytometry Systems (USA).